In a research note published by Charles Eden, UBS advises its customers to Sell the stock. The target price continues to be set at CHF 2820. | May 17, 2023
In a research note, JP Morgan analyst Celine Pannuti has maintained his recommendation on the stock with a Neutral rating. The target price is still set at CHF 3100. | April 19, 2023
In his latest research note, analyst Gunther Zechmann confirms his negative recommendation. The broker Bernstein is keeping its Sell rating. The target price remains set at CHF 2550. | April 18, 2023